Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
(1) Organization and Business Description
AmpliTech Group, Inc. (“AmpliTech” or the “Company”) was incorporated under the laws of the State of Nevada on December 30, 2010. On August 13, 2012, the Company acquired AmpliTech, Inc., by issuing 833,750 shares of the Company’s common stock to the shareholders of AmpliTech, Inc. in exchange for 100% of the outstanding shares of AmpliTech Inc. (the “Share Exchange”). After the Share Exchange, the selling shareholders owned 60,000 shares of the outstanding 889,250 shares of Company common stock, resulting in a change in control. Accordingly, the transaction was accounted for as a reverse acquisition in which AmpliTech, Inc. was deemed to be the accounting acquirer, and the operations of the Company were consolidated for accounting purposes. The capital balances have been retroactively adjusted to reflect the reverse acquisition.
AmpliTech designs, engineers and assembles microwave component based low noise amplifiers (“LNA”) that meet individual customer specifications. Application of the Company’s proprietary technology results in maximum frequency gain with minimal background noise distortion as required by each customer. The Company has both domestic and international customers in such industries as aerospace, governmental, defense and commercial satellite.
On September 12, 2019, AmpliTech Group, Inc. acquired the assets of Specialty Microwave Corporation (“Specialty”), a privately held company based in Ronkonkoma, NY. The purchase included all inventory, orders, customers, property and equipment, and all intellectual property. The assets also included all eight team members of Specialty.
Specialty designs and manufactures passive microwave components and related subsystems that meet individual customer specifications for both domestic and international customers for use in satellite communication ground networks.
On February 17, 2021, AmpliTech Group, Inc., common stock and warrants under the symbols “AMPG” and “AMPGW”, respectively, commenced trading on NASDAQ. A reverse split of the outstanding common stock at a 1-for-20 ratio became effective February 17, 2021 as of 12:01 a.m., Eastern Time. In connection with the public offering, 1,371,428 units at an offering price of $7.00 per unit were sold. Each unit issued in the offering consisted of one share of common stock and one warrant.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
On November 19, 2021, AmpliTech Group, Inc. entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Spectrum Semiconductor Materials Inc. (the "Seller" or “SSM”), pursuant to which AmpliTech would acquire substantially all the assets of the Company (the “Acquisition”). The Acquisition was completed on December 15, 2021.
Spectrum Semiconductor Materials ("SSM”), located in Silicon Valley (San Jose, CA), is a global authorized distributor of integrated circuit ("IC") packaging and lids for semiconductor device assembly, prototyping, testing, and production requirements.
In August 2022, AmpliTech Group True G Speed Services (“TGSS”) division was formed to enable “true G speeds” to the industry. TGSS’ main function will be to plan and configure 5G radio systems and make them Open Radio Access Network compliant. TGSS will implement AmpliTech’s low noise amplifier devices in these systems to promote greater coverage, longer range and faster speeds.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The COVID-19 Pandemic
The COVID-19 pandemic had disrupted and affected our business operations, which has led to business and supply chain disruptions. The lingering effects of the pandemic are likely to continue to disrupt our business and supply chain in the future. For example, our offices and R&D and manufacturing locations had been, and may continue to be, impacted due to national and regional government declarations requiring closures, quarantines, and travel restrictions, although nearly all government-imposed restrictions have been significantly reduced in most parts of the world. However, given the unpredictable nature of COVID-19 and its variants, it is difficult, if not impossible, to predict, whether any government-imposed restrictions will be reimposed at previous levels or enhanced in one or more ways impacting our business operations or those of third parties upon which we rely. The COVID-19 pandemic, including associated business interruptions and recovery, as well as other possible epidemics or outbreaks of other contagions could result in a material adverse impact on our or our current or anticipated customers’ or suppliers’ business operations, including reduction or suspension of operations in the U.S. or other parts of the world. Our design and engineering operations, among others, cannot all be conducted remotely and often require on-site access to materials and equipment. We have customers, suppliers, and partners with international operations, and our customers, suppliers, and partners also depend on suppliers and manufacturers worldwide, which means that our business and prospects could be affected by the lingering effects of the COVID-19 pandemic anywhere in the world. Depending upon the duration of the lingering effects of the COVID-19 pandemic and the associated business interruptions, our customers, suppliers, manufacturers, and partners may suspend or delay their engagements with us. We and our customers’ and suppliers’ response to the lingering effects of the COVID-19 pandemic may prove to be inadequate and they may be unable to continue their respective operations in the manner they had prior to the outbreak or the worsening of the outbreak, and we may consequently endure interruptions, reputational harm, delays in our product development, and shipments, all of which could have an adverse effect on our business, operating results, and financial condition. In addition, we cannot assure you as to the timing of the economic recovery given the lingering effects of the pandemic, which could have a material adverse effect on our target markets and our business.
(2) Summary of Significant Accounting Policies
Basis of Accounting
The accompanying consolidated financial statements have been prepared using the accrual basis of accounting.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers deposits that can be redeemed on demand and investments and marketable securities that have original maturities of less than three months, when purchased, to be cash equivalents. As of December 31, 2022, the Company’s cash and cash equivalents were deposited in four financial institutions.
Accounts Receivable
Trade accounts receivables are recorded at the net invoice value and are not interest bearing.
The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company’s estimate is based on historical collection experience and a review of the status of accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change in the future. An allowance of $ 0 and $39,380 has been recorded at December 31, 2022 and 2021, respectively.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Employee Retention Credit
The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) provided an employee retention credit which was a refundable tax credit against certain employment taxes. New legislation amended the employee retention credit to be equal to 70% of qualified wages paid to employees after December 31, 2020, and before January 1, 2022. During calendar year 2021, a maximum of $10,000 in qualified wages for each employee per qualifying calendar quarter may be counted in determining the 70% credit. Therefore, the maximum tax credit that can be claimed by an eligible employer is $7,000 per employee per qualifying calendar quarter of 2021. The Company qualifies for the employee retention credit for quarters that experience a significant decline in gross receipts, defined as quarterly gross receipts that are less than 80 percent of its gross receipts for the same calendar quarter in 2019. The Company qualified for the credit beginning on January 1, 2021 and received credits for qualified wages through June 30, 2021. During the year ended December 31, 2021, the Company recorded an employee retention credit totaling $201,215, which was collected in 2022.
Marketable Securities
The Company’s investments in marketable securities are classified based on the nature of the securities and their availability for use in current operations. The Company’s marketable securities are stated at fair value with all realized and unrealized gains and losses on investments in marketable equity securities recognized in other income, net. The realized and unrealized gains and losses on marketable securities are determined using specific identification method.
Inventories
Inventories, which consists primarily of raw materials, work in progress, and finished goods, are stated at the lower of cost (first-in, first-out basis) or market (net realizable value).
Inventory quantities and related values are analyzed at the end of each fiscal quarter to determine those items that are slow moving and obsolete. An inventory reserve is recorded for those items determined to be slow moving with a corresponding charge to cost of goods sold. Inventory items that are determined obsolete are written off currently with a corresponding charge to cost of goods sold.
As of December 31, 2022 and 2021, the reserve for inventory obsolescence was $1,128,000 and $1,031,986, respectively.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Property and Equipment
Property and equipment are recorded at cost. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.
Property and equipment are depreciated as follows:
Description | | Useful Life | | Method |
Office equipment | | 3 to 10 years | | Straight-line |
Machinery/shop equipment | | 7 to 10 years | | Straight-line |
Computer equipment/software | | 1 to 7 years | | Straight-line |
Vehicles | | 5 years | | Straight-line |
Leasehold improvements | | 7 years | | Straight-line |
Long-lived assets
The Company reviews its property and equipment and right-of-use (“ROU”) assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. The test for impairment is required to be performed by management upon triggering events. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. There were no impairments of long-lived assets for the years ended December 31, 2022 and 2021.
Intangible assets
The Company periodically evaluates the reasonableness of the useful lives of these assets. These assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. If impaired, intangible assets are written down to fair value based on discounted cash flows or other valuation techniques. The Company has no intangibles with indefinite lives. There were no impairments of intangible assets for the years ended December 31, 2022 and 2021.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Goodwill
We follow the acquisition method of accounting to record the assets and liabilities of acquired businesses at their estimated fair value at the date of acquisition. We initially record goodwill for the amount the consideration transferred exceeds the acquisition-date fair value of net identifiable assets acquired.
We test goodwill for impairment at a level within the Company referred to as the reporting unit, which is our business segment level or one level below the business segment. We test our goodwill for impairment annually on December 31, or under certain circumstances more frequently, such as when events or circumstances indicate there may be impairment. Such events or circumstances may include a significant deterioration in overall economic conditions, changes in the business climate of our industry, a decline in our market capitalization, operating performance indicators, competition, reorganizations of our business or the disposal of all or a portion of a reporting unit.
To test goodwill for impairment, we may perform both qualitative and quantitative assessments. If we elect to perform a qualitative assessment for a certain reporting unit, we evaluate events and circumstances impacting the reporting unit to determine the probability that goodwill is impaired. If we perform a quantitative assessment for a certain reporting unit, we calculate the fair value of that reporting unit and compare the fair value to the reporting unit’s net book value. We estimate fair values of our reporting units based on projected cash flows, and sales and/or earnings multiples applied to the latest twelve months’ sales and earnings of our reporting units. Projected cash flows are based on our best estimate of future sales, operating costs and balance sheet metrics reflecting our view of the financial and market conditions of the underlying business; and the resulting cash flows are discounted using an appropriate discount rate that reflects the risk in the forecasted cash flows.
If we determine it is more-likely-than-not that the fair value of the reporting unit is less than its carrying amount, we measure any loss from an impairment by comparing the fair value of each reporting unit to its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, goodwill is considered impaired, and an impairment loss is recognized in an amount equal to that excess. Goodwill impairments for the years ended December 31, 2022 and 2021, were $120,136 and $0, respectively.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Investment Policy-Cost Method
Investments consist of non-controlling equity investments in privately held companies. The Company elected the measurement alternative for these investments without readily determinable fair values and for which the Company does not control or have the ability to exercise considerable influence over operating and financial policies. These investments are accounted for under the cost method of accounting. Under the cost method of accounting, the non-marketable equity securities are carried at cost less any impairment, adjusted for observable price changes of similar investments of the same issuer. Fair value is not estimated for these investments if there are no identified events or changes in circumstances that may influence the fair value of the investment. Under this method, the Company’s share of the earnings or losses of such investee companies is not included in the consolidated balance sheet or consolidated statements of operations. The Company held $348,250 and $250,000, respectively of investments without readily determinable fair values at December 31, 2022 and 2021. (see Note 10). These investments are included in other assets on the consolidated balance sheets. There were no indicators of impairment during the year ended December 31, 2022 and 2021.
Leases
We lease property and equipment under finance and operating leases. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the lease term. The Company has elected not to separate lease and non-lease components for all property leases for the purpose of calculating ROU assets and lease liabilities. Many of our leases include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when appropriate. When available, we use the rate implicit in the lease to discount lease payments to present value; however, most of our leases do not provide a readily determinable implicit rate. Therefore, we must estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow on a collateralized basis considering such factors as lease term and economic environment risks.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Revenue Recognition
We sell our products through a combination of a direct sales force in the United States and independent sales representatives in international markets. Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods. This core principle is achieved through the following steps:
Identify the contract with the customer. A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred.
Identify the performance obligations in the contract. Our contracts with customers do not include multiple performance obligations to be completed over a period.
Our performance obligations relate to delivering single-use products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds.
We do not have significant returns. We do not typically offer extended warranty or service plans.
Determine the transaction price. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. None of our contracts as of December 31, 2022 contained a significant financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.
Allocate the transaction price to performance obligations in the contract. We typically do not have multiple performance obligations in our contracts with customers. As such, we generally recognize revenue upon transfer of the product to the customer's control at contractually stated pricing.
Recognize revenue when or as we satisfy a performance obligation. We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue.
Cost of Sales
We include product costs such material, direct labor, overhead costs, production-related depreciation expense, outside labor and production supplies in cost of sales.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Shipping and Handling
Shipping and handling charges are generally incurred at the customer’s expense. However, when billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.
Research and Development
Research and development expenditures are charged to operations as incurred. The major components of research and development costs include consultants, outside service, and supplies.
Research and development costs for the years ended December 31, 2022 and 2021 were $1,024,127 and $1,833,399, respectively.
Income Taxes
The Company’s deferred tax assets and liabilities for the expected future tax consequences of events have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and tax bases of certain assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. At December 31, 2022 and 2021, the Company had no material unrecognized tax benefits.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Earnings Per Share
Basic earnings per share (“EPS”) are determined by dividing the net earnings by the weighted-average number of shares of common shares outstanding during the period. Diluted EPS is determined by dividing net earnings by the weighted average number of common shares used in the basic EPS calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding under the treasury stock method. As of December 31, 2022 and 2021, there were 4,235,442 and 3,818,142, respectively, potentially dilutive shares that need to be considered as common share equivalents. As a result of the net loss, the potentially dilutive shares that need to be considered as common share equivalents, for the years ended December 31, 2022 and 2021, are anti-dilutive.
The computation of weighted average shares outstanding and the basic and diluted earnings per share consisted of the following:
| | Net Loss | | | Shares | | | Per Share Amount | |
| | | | | | | | | |
For the year ended December 31, 2022: | | | | | | | | | |
Basic EPS | | $ | (677,107 | ) | | | 9,609,208 | | | $ | (0.07 | ) |
Effect of dilutive stock options and warrants | | | - | | | | - | | | | | |
Diluted EPS | | $ | (677,107 | ) | | | 9,609,208 | | | $ | (0.07 | ) |
| | | | | | | | | | | | |
For the year ended December 31, 2021: | | | | | | | | | | | | |
Basic EPS | | $ | (4,758,805 | ) | | | 8,900,824 | | | $ | (0.53 | ) |
Effect of dilutive stock options and warrants | | | - | | | | - | | | | | |
Diluted EPS | | $ | (4,758,805 | ) | | | 8,900,824 | | | $ | (0.53 | ) |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Fair Value Measurements
The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined in the following three categories:
Level 1: Unadjusted quoted prices that are available in active markets for identical assets or liabilities at the measurement date.
Level 2: Significant other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly.
Level 3: Significant unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment.
Cash and cash equivalents, receivables, inventories, prepaid expenses, accounts payable, accrued expenses, and customer deposits approximate fair value, due to their short-term nature. The carrying value of notes payable and short and long-term debt also approximates fair value since these instruments bear market rates of interest.
Assets and liabilities that are measured at fair value on a nonrecurring basis relate primarily to long-lived assets, intangible assets, and goodwill, which are remeasured when the derived fair value is below carrying value in the consolidated balance sheets.
Stock-Based Compensation
The Company records stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued and are recognized over the employees required service period, which is generally the vesting period.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Concentration of Credit Risk
Financial instruments that potentially subject the company to concentration of credit risk consist primarily of cash and accounts receivable.
Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2022 and 2021, the Company had $12,040,022 and $17,018,874 in excess of the FDIC insured limit, respectively.
The Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses. Therefore, management does not believe significant credit risks exist at December 31, 2022.
Sales to the Company’s largest customer represented approximately 18.41%of total sales for the year ended December 31, 2022.As of December 31, 2021, there were two customers that each accounted for 25.98% and 10.60% of our total revenue.
There were two vendors that accounted for 44.15% and 29.29%, respectively, and one vendor that accounted for 44.73% of total component parts purchased as of December 31, 2022 and 2021.
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The amendments in this update, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. As a smaller reporting company, the guidance is effective for our fiscal years beginning after December 15, 2022. The Company does not expect the adoption of this ASU to have a material impact on the consolidated financial statements and related disclosures.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU amends ASC 805 to require acquiring entities to apply ASC 606 to recognize and measure contract assets and contract liabilities in business combinations. The standard is effective for the Company’s fiscal year beginning January 1, 2023, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on the consolidated financial statements and related disclosures.
In March 2022, the FASB issued ASU 2022-02, Troubled Debt Restructurings (“TDRs”) and Vintage Disclosures (Topic 326): Financial Instruments – Credit Losses. This amended guidance will eliminate the accounting designation of a loan modification as a TDR, including eliminating the measurement guidance for TDRs. The amendments also enhance existing disclosure requirements and introduce new requirements related to modifications of receivables made to borrowers experiencing financial difficulty. Additionally, this guidance requires entities to disclose gross write-offs by year of origination for financing receivables, such as loans and interest receivable. The ASU is effective January 1, 2023, and is required to be applied prospectively, except for the recognition and measurement of TDRs which can be applied on a modified retrospective basis. The Company does not expect the adoption of this ASU to have a material impact on the consolidated financial statements and related disclosures.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
(3) Revenues
The following table presents sales disaggregated based on geographic regions and for the years ended:
| | December 31, | | | December 31, | |
| | 2022 | | | 2021 | |
AmpliTech Inc. | | | | | | |
Domestic sales | | $ | 4,922,237 | | | $ | 2,865,872 | |
International sales | | | 947,515 | | | | 524,019 | |
Total sales | | $ | 5,869,752 | | | $ | 3,389,891 | |
| | | | | | | | |
Spectrum | | | | | | | | |
Domestic sales | | $ | 6,798,713 | | | $ | 153,349 | |
International sales | | | 6,726,027 | | | | 1,732,194 | |
Total sales | | $ | 13,524,740 | | | $ | 1,885,543 | |
Total sales for the year ended December 31, 2022 and 2021, were $19,394,492 and $5,275,434, respectively.
(4) Segment Reporting
ASC 280, “Segment Reporting”, establishes standards for reporting information about operating segments on a basis consistent with the Company's internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for details on the Company's business segments.
The following table presents summary information by segment for the year ended December 31, 2022:
| | AmpliTech Inc. | | | Spectrum | | | Corporate | | | Total | |
Revenue | | $ | 5,869,752 | | | $ | 13,524,740 | | | | - | | | $ | 19,394,492 | |
Cost of Goods Sold | | | 3,257,367 | | | | 7,212,261 | | | | - | | | | 10,469,628 | |
Net Income (Loss) | | | (2,478,429 | ) | | | 2,878,476 | | | | (1,077,154 | ) | | | (677,107 | ) |
Total Assets | | | 17,682,013 | | | | 16,979,383 | | | | 2,018,238 | | | | 36,679,634 | |
Depreciation and Amortization | | | 279,470 | | | | 132,536 | | | | - | | | | 412,006 | |
Interest Expense, net | | | (159 | ) | | | 1,289 | | | | 11,883 | | | | 13,013 | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The following table presents summary information by segment for the year December 31, 2021:
| | AmpliTech Inc. | | | Spectrum | | | Corporate | | | Total | |
Revenue | | $ | 3,389,891 | | | $ | 1,885,543 | | | | - | | | $ | 5,275,434 | |
Cost of Goods Sold | | | 2,783,432 | | | | 1,199,365 | | | | - | | | | 3,982,797 | |
Net Income (Loss) | | | (3,198,767 | ) | | | 435,974 | | | | (1,996,012 | ) | | | (4,758,805 | ) |
Total Assets | | | 15,066,555 | | | | 15,201,516 | | | | 4,959,117 | | | | 35,227,188 | |
Depreciation and Amortization | | | 145,191 | | | | 1,429 | | | | - | | | | 146,620 | |
Interest Expense, net | | | (1,665 | ) | | | - | | | | 44,471 | | | | 42,806 | |
(5) Acquisition of Spectrum Semiconductors Materials
On December 15, 2021, AmpliTech Group Inc. acquired Spectrum Semiconductor Materials (SSM), an “S” Corporation located in Silicon Valley (San Jose, CA). Spectrum Semiconductor Materials ("SSM”) is a global authorized distributor of integrated circuit ("IC") packaging and lids for semiconductor device assembly, prototyping, testing, and production requirements.
The purchase is expected to deliver significant strategic and top and bottom-line benefits while also building on AmpliTech’s technical and management expertise and distribution reach.
The purchase included all accounts receivables, accounts payable, inventory, orders, customers, property and equipment and intellectual property. The aggregate purchase price for the acquisition was $10,123,276 subject to certain working capital and other adjustments of which $665,200 was paid by the issuance of 188,442 unregistered shares of AmpliTech common stock at the closing of the Acquisition.
Simultaneously with the execution of the Purchase Agreement, $1,500,000 was deposited into escrow, comprising of a $750,000, “Purchase Price Adjustment Escrow Fund” and a $750,000, “Indemnification Escrow Fund”. The Purchase Price Adjustment Escrow Fund will be available for the payment of any working capital adjustment owed by Seller to Buyer or Buyer to Seller pursuant to and in accordance with the Purchase Agreement.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The Indemnification Escrow Fund will be available to satisfy any losses incurred or sustained by or imposed upon the Indemnified Parties pursuant to and in accordance with the Purchase Agreement. The escrow release date is March 31, 2023.
Within sixty (60) days after the Closing Date, AmpliTech prepared and delivered to Seller a statement setting forth its calculation of Closing Working Capital of the Business, according to the terms of the Purchase Agreement. The “Working Capital Adjustment” shall be an amount equal to the Closing Working Capital minus $3,296,427. If the Working Capital Adjustment is a positive number, Buyer shall pay to Seller an amount equal to the Working Capital Adjustment. If the Working Capital Adjustment is a negative number, Seller shall pay to Buyer an amount equal to the Working Capital Adjustment. The Working Capital Adjustment was determined to be $708,076 owed to Seller.
Within forty (40) days after December 31, 2022, AmpliTech prepared and delivered to Seller a statement setting forth its calculation of Two Years Net Revenues of the business, or the “Revenue Statement”. The Revenues Adjustment shall be an amount equal to 25% of two years net revenues minus $20,000,000. If the Revenues Adjustment is a positive number, Buyer shall pay to Seller an amount equal to the Revenues Adjustment. If the Revenues Adjustment is a negative number, Seller shall pay to Buyer and amount equal to the Revenues Adjustment. The fair value of the revenue adjustment was determined to be $2,180,826 an increase of $815,788 as previously recorded in December 31, 2021. This amount is owed to Seller and recorded as a contingent liability as of December 31, 2022.
The Purchase Agreement contains representations, warranties, and covenants believed to be customary for a transaction of this nature, including covenants as to indemnification for breaches of certain representations, warranties and covenants, subject to certain exclusions and caps. Further, the completion of the Acquisition is subject to release of all liens and to the satisfaction of closing conditions, including the continued employment of certain Company employees.
The fair value of the purchase consideration issued to Spectrum Semiconductor Materials was allocated to the net tangible assets acquired. The Company accounted for the Acquisition as the purchase of a business under GAAP under the acquisition method of accounting, and the assets and liabilities acquired were recorded as the acquisition date, at their respective fair values and consolidated with those of the Company. The fair value of the net assets acquired was approximately $4,098,516. The excess of the aggregate fair value of the net tangible assets has been allocated to net intangible assets of $7,389,794.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The following table summarizes the allocation of the purchase price of the acquisition:
Purchase consideration at fair value: | | | |
Cash | | $ | 8,000,000 | |
Common stock | | | 665,200 | |
Net working capital adjustment | | | 708,076 | |
Indemnification escrow amount | | | 750,000 | |
Fair value of revenue earnout | | | 1,365,038 | |
Total purchase price | | $ | 11,488,314 | |
| | | | |
Allocation of purchase price: | | | | |
Working Capital | | $ | 3,730,133 | |
Property and Equipment | | | 99,188 | |
Goodwill | | | 4,696,883 | |
Tradename | | | 514,284 | |
Customer relationships | | | 2,178,631 | |
Right of Use operating lease asset | | | 858,508 | |
Right of Use operating lease liability | | | (619,271 | ) |
Other asset | | | 29,958 | |
Net assets acquired | | $ | 11,488,314 | |
From the date of acquisition until December 31, 2021, SSM contributed revenue of $1,885,543 and net income from continuing operations of $435,974 which are included in our consolidated statement of operations.
(6) Marketable Securities
The following table is a summary of marketable securities at December 31, 2022:
| | Adjusted Cost | | | Unrealized Gains | | | Unrealized Loss | | Fair Value | |
Level 1 (1) | | | | | | | | | | | |
Money Market Fund | | $ | 1,759,299 | | | - | | | - | | $ | 1,759,299 | |
US Treasury Bills | | | 245,172 | | | | 2,278 | | | - | | | 247,450 | |
Total | | $ | 2,004,471 | | | $ | 2,278 | | | - | | $ | 2,006,749 | |
The following table is a summary of marketable securities at December 31, 2021:
| | Adjusted Cost | | | Unrealized Gains | | | Unrealized Losses | | | Fair Value | |
Level 1 (1) | | | | | | | | | | | | |
Money Market Fund | | $ | 4,931,960 | | | | - | | | | - | | | $ | 4,931,960 | |
Marketable Equitable Securities | | | - | | | | - | | | | - | | | | - | |
| | | | | | | | | | | | | | | | |
Total | | $ | 4,931,960 | | | | - | | | | - | | | $ | 4,931,960 | |
Cash and cash equivalents in our marketable securities account at December 31, 2022 and 2021 was $1,759,299 and $4,931,960, respectively.
During the year ended December 31, 2021, the Company sold all of their marketable securities, resulting in a realized a loss of $97,862.
| (1) | Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities. |
When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of December 31, 2022 and 2021, the Company did not consider any of its investments to be impaired.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
(7) Inventories
The inventory consists of the following at December 31, 2022 and 2021:
| | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Raw Materials | | $ | 872,184 | | | $ | 609,841 | |
Work-in Progress | | | 229,771 | | | | 162,072 | |
Finished Goods | | | 6,658,166 | | | | 4,452,885 | |
Subtotal | | $ | 7,760,121 | | | $ | 5,224,798 | |
Less: Reserve for Obsolescence | | | (1,128,000 | ) | | | (1,031,986 | ) |
Total | | $ | 6,632,121 | | | $ | 4,192,812 | |
(8) Property and Equipment
Property and Equipment consisted of the following at December 31, 2022 and 2021:
| | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Lab Equipment | | $ | 2,455,045 | | | $ | 1,893,564 | |
Manufacturing Equipment | | | 129,745 | | | | 25,000 | |
Automobiles | | | 7,335 | | | | 7,335 | |
Computer Equipment and Software | | | 210,240 | | | | 159,315 | |
Leasehold Improvements | | | 78,042 | | | | - | |
Furniture and Fixtures | | | 148,987 | | | | 27,504 | |
Subtotal | | | 3,029,394 | | | | 2,112,718 | |
Less: Accumulated Depreciation | | | (1,005,707 | ) | | | (757,430 | ) |
| | | | | | | | |
Total | | $ | 2,023,687 | | | $ | 1,355,288 | |
Depreciation expense for the years ended December 31, 2022 and 2021 was $262,032 and $105,578, respectively, of which $194,456 and $95,145, respectively were included in cost of goods sold.
Property and equipment purchased in the amount of $234,036 under a financing lease is included in the totals above.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
(9) Goodwill and Intangible Assets
Goodwill
Goodwill is related to the acquisition of Specialty on September 12, 2019 and the acquisition of Spectrum Semiconductor Materials Inc. on December 15, 2021. Goodwill is primarily related to expected improvements and technology performance and functionality, as well sales growth from future product and service offerings and new customers, together with certain intangible assets that do not qualify for separate recognition. Goodwill is generally not amortizable for tax purposes and is not amortizable for financial statement purposes. As of December 31, 2022, goodwill related to the acquisition of Specialty was deemed impaired in the amount of $120,136. As of December 31, 2022 and 2021, goodwill was $4,696,883 and $4,817,019 respectively.
Other Intangible Assets
Intangible assets with an estimated useful life of fifteen and twenty years consisted of the following at December 31, 2022:
| | Gross Carrying Amount | | | Accumulated Amortization | | | Net | | | Weighted Average Life | |
Trade name | | $ | 584,517 | | | $ | - | | | $ | 584,517 | | | Indefinite | |
Customer relationships | | | 2,591,491 | | | | 199,875 | | | | 2,391,616 | | | | 17.81 | |
Intellectual Property | | | 202,771 | | | | 44,797 | | | | 157,974 | | | | 11.71 | |
| | | | | | | | | | | | | | | | |
Total | | $ | 3,378,779 | | | $ | 244,672 | | | $ | 3,134,107 | | | | | |
Amortization expense for the years ended December 31, 2022 and 2021 was $149,974 and $41,042, respectively.
Annual amortization of intangible assets are as follows:
2023 | | | 149,976 | |
| | | | |
2024 | | | 149,976 | |
| | | | |
2025 | | | 149,976 | |
| | | | |
2026 | | | 149,976 | |
| | | | |
2027 | | | 149,976 | |
Thereafter | | | 1,799,710 | |
| | $ | 2,549,590 | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
(10) Cost Method Investment
On June 10, 2021, the Company entered into a membership interest purchase agreement with SN2N, LLC for an aggregate purchase price of $350,000, to be paid in four tranches. Each tranche represents a 5% membership interest, and in aggregate a 20% membership interest. On June 15, 2022, an amendment to the membership interest purchase agreement was made to reflect a 19.9% membership interest. In light of this amendment, the Company overpaid by $1,750 for the membership interest and was subsequently reimbursed. As of December 31, 2022, the Company has made an investment of $348,250 for a 19.9% membership interest.
(11) Line of Credit
On November 20, 2021, AmpliTech renewed its business line of credit for $750,000 maturing on November 1, 2022. The line is evaluated monthly on a borrowing base formula advancing 75% of accounts receivables aged less than 90 days and 50% of inventory raw materials costs not to exceed $250,000. The interest rate shall be based upon the Wall Street Journal Prime Rate, plus 1%. The Company has the option to prepay all or any portion of the amount owed prior to its due date without penalty.
In connection with the loan, the Company granted the lender a security interest in all its respective assets. In addition, the President and CEO, has agreed to guarantee the loan.
As of December 31, 2022 and 2021, the outstanding balance on the line of credit was $0.
As of March 14, 2023, the Company closed the line of credit of $750,000. All UCC filings on the Company assets have been released as well as the President’s personal guarantee.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
(12) Leases
The following was included in our balance sheet as of December 31, 2022 and 2021:
| | December 31, | | | December 31, | |
Operating leases | | 2022 | | | 2021 | |
Assets | | | | | | |
ROU operating lease assets | | $ | 4,197,324 | | | $ | 1,115,588 | |
| | | | | | | | |
Liabilities | | | | | | | | |
Current portion of operating lease | | $ | 586,379 | | | $ | 391,571 | |
Operating lease, net of current portion | | $ | 3,768,932 | | | $ | 795,317 | |
Total operating lease liabilities | | $ | 4,355,311 | | | $ | 1,186,888 | |
| | | | | | | | |
Financing leases | | | | | | | | |
Assets | | | | | | | | |
Property and equipment, gross | | $ | 234,036 | | | $ | 157,184 | |
Accumulated depreciation | | | (113,621 | ) | | | (78,592 | ) |
Property and equipment, net | | $ | 120,415 | | | $ | 78,592 | |
| | | | | | | | |
Liabilities | | | | | | | | |
Current portion of financing lease | | $ | 33,480 | | | $ | 33,688 | |
Financing lease, net of current portion | | $ | 49,336 | | | $ | 17,471 | |
Total financing lease liabilities | | $ | 82,816 | | | $ | 51,159 | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The weighted average remaining lease term and weighted average discount rate at December 31, 2022 and 2021 were as follows:
Weighted average remaining lease term (years) | | December 31, 2022 | | | December 31, 2021 | |
Operating leases | | | 9.40 | | | | 3.01 | |
Financing leases | | | 2.80 | | | | 1.50 | |
Weighted average discount rate | | | | | | | | |
Operating leases | | | 4.49 | % | | | 4.25 | % |
Financing leases | | | 4.70 | % | | | 4.89 | % |
Financing Lease
The Company entered into several 60-month lease agreements to finance certain laboratory and office equipment. As such, the Company has accounted for these transactions as a financing lease.
The following table reconciles future minimum financing lease payments to the discounted lease liability as of December 31, 2022:
2023 | | | 36,472 | |
2024 | | | 18,751 | |
2025 | | | 18,186 | |
2026 | | | 11,976 | |
Thereafter | | | 3,992 | |
Total lease payments | | | 89,377 | |
Less imputed interest | | | (6,561 | ) |
Total lease obligations | | | 82,816 | |
Less current obligations | | | (33,480 | ) |
Long-term lease obligations | | $ | 49,336 | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Operating Leases
On December 4, 2015, the Company entered into a new operating lease agreement to rent office space in Bohemia, NY. This five-year agreement commenced February 1, 2016 with an annual rent of $50,000 and 3.75% increases in each successive lease year. On January 13, 2021, a lease rider was annexed to the original lease whereby the lease term will be extended on a month-by-month basis, commencing on February 1, 2021. The lease was terminated in April 2022.
On September 12, 2019, the Company entered into a new operating lease agreement to rent office space in Ronkonkoma, NY. This five- year agreement commenced on September 12, 2019 with an annual rent of $90,000 and 3% increase in each successive lease year beginning in 2021. The Company has an option to buy the property during the first two years of the lease for $1,200,000 and then at fair market value for the remainder of the lease term. This option has expired and was not exercised as of December 31, 2022.
On November 27, 2019, the Company entered a 39-month agreement to lease an automobile with a monthly payment of $420.
On December 15, 2021, the Company assumed the SSM lease agreement for office and warehouse space in San Jose, CA, with the same terms and conditions. Effective February 1, 2020, the lease term will expire on January 31, 2025 with a base rent of $24,234 for the first 12 months and increase by approximately 3% every year.
On October 15, 2021, the Company entered into a new lease for a 20,000 square foot facility at 155 Plant Avenue, Hauppauge, New York, for a term of seven years and two months. The yearly base rent of $346,242 shall increase at a rate of 2.75% per year to begin on the first anniversary lease commencement date and each year thereafter. The first two months of basic rent shall be abated following the commencement lease date. In the event the landlord decides to sell the property, the Company shall have the right of first offer to purchase subject property. Upon lease execution, the Company paid two months of base rent as a security deposit and one month’s rent totaling $86,560. The Company moved into the new manufacturing and headquarters facility April 1, 2022.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The following table reconciles future minimum operating lease payments to the discounted lease liability as of December 31, 2022:
2023 | | | 768,465 | |
2024 | | | 765,075 | |
2025 | | | 400,321 | |
2026 | | | 383,347 | |
Thereafter | | | 3,112,070 | |
Total lease payments | | | 5,429,278 | |
Less imputed interest | | | (1,073,967 | ) |
Total lease obligations | | | 4,355,311 | |
Less current obligations | | | (586,379 | ) |
Long-term lease obligations | | $ | 3,768,932 | |
(13) Notes Payable
Promissory Note:
On September 12, 2019, AmpliTech Group, Inc. acquired Specialty, a privately held company based in Ronkonkoma, NY. The purchase included all inventory, orders, customers, property and equipment, and all intellectual property. The assets also included all eight team members of Specialty. The total consideration paid was $1,143,633, consisting of $668,633 in cash and a $475,000 promissory note with an interest rate of 6%. Beginning November 1, 2019, payment of principal and interest shall be due payable in fifty-nine (59) monthly payments of $9,213 with a final payment due October 1, 2024 of $9,203. As of December 31, 2022 and 2021, the balance of this promissory note was $183,014 and $279,119, respectively. Principal payments of $96,105 and $90,397 along with interest expense of $14,460 and $20,167 was paid during the years ended December 31, 2022 and 2021, respectively.
Loan Payable:
On September 12, 2019, the Company was approved for a $250,000 equipment leasing facility which was subsequently increased to $500,000. The Company has borrowed against the leasing facility as follows:
| · | On December 20, 2019, the Company borrowed $58,192 to be paid over a three-year term with monthly payments of $1,736 at an interest rate of 5.26%. The balance as of December 31, 2022 and 2021 was $0 and $18,630, respectively. Principal payments of $18,630 and $19,381 were made for the years ended December 31, 2022 and 2021, respectively. Total interest expense paid for the years ended December 31, 2022 and 2021 was $466 and $1,451, respectively. |
| | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
| · | On May 14, 2020, the Company borrowed $27,494 to be paid over a three-year term with monthly payments of $815 at an interest rate of 4.268%. The balance as of December 31, 2022 and 2021 was $3,230 and $12,632, respectively. Principal payments of $9,402 and $12,632, were made for the years ended December 31, 2022 and 2021, respectively. Total interest expense paid for the years ended December 31, 2022 and 2021 was $378 and $792, respectively. |
| · | On June 10, 2020, the Company borrowed $41,015 to be paid over a three-year term with monthly payments of $1,216 at an interest rate of 4.278. The balance as of December 31, 2022 and 2021 was $6,012 and $19,986, respectively. Principal payments of $13,975 and $13,357 were made for the years ended December 31, 2022 and 2021, respectively. Total interest expense paid for the years ended December 31, 2022 and 2021 was $617 and $1235, respectively. |
| · | On May 6, 2022, the Company borrowed $441,139 to be paid over a three-year term with monthly payments of $13,341 at an interest rate of 5.6%. On June 15, 2022, this equipment order was cancelled resulting in a full refund of $441,139 less interest paid of $6,317. The loan was repaid in August 2022. |
As of March 14, 2023, the Company closed the equipment line of credit of $500,000, which had $0 balance. All UCC filings on the Company assets have been released as well as the President’s personal guarantee.
In January 2022, the Company purchased machinery for $91,795, applying a deposit of $9,180 and financing the balance of $82,616 over 24 payments at an interest rate of 1.90%. The balance as of December 31, 2022 was $41,700. Principal payments of $40,916 and interest expense of $1,215 was paid for the year ended December 31 , 2022.
Future principal payments over the term of the loans as of December 31, 2022 are as follows:
| | Payments | |
2023 | | $ | 144,358 | |
2024 | | | 89,597 | |
Total remaining payments | | $ | 233,955 | |
(14) Income Taxes
The difference between the income tax expense (benefit) reported and amounts computed by applying the statutory federal rate of 21.0% to pretax loss for the years ended December 31, 2022 and 2021 is as follows:
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
| | December 31, | |
| | 2022 | | | 2021 | |
Federal and state net operating loss | | $ | (132,999 | ) | | $ | (999,349 | ) |
Meals & entertainment | | | 2,634 | | | | 8,830 | |
Life insurance | | | 5,182 | | | | 3,919 | |
Goodwill | | | (7,162 | ) | | | (7,162 | ) |
SBA PPP Loan | | | - | | | | 48,762 | |
Stock-based compensation | | | 83,816 | | | | 153,715 | |
Depreciation | | | (55,027 | ) | | | (25,493 | ) |
State tax, net of federal benefit | | | 31,666 | | | | 183,643 | |
Other | | | - | | | | - | |
Tax rate change | | | | | | | - | |
Change in Valuation Allowance | | | 71,890 | | | | 633,135 | |
Total income tax provision | | $ | - | | | $ | - | |
The provision for Federal income tax consists of the following for the years ended December 31, 2022 and 2021:
| | December 31, | |
| | 2022 | | | 2021 | |
Net operating loss carryforwards | | $ | 1,197,903 | | | $ | 1,082,454 | |
Depreciation | | | (123,185 | ) | | | (68,158 | ) |
Allowance for doubtful accounts | | | 18,509 | | | | 10,239 | |
Goodwill amortization | | | (18,805 | ) | | | (11,643 | ) |
Stock based compensation | | | | | | | - | |
Inventory reserve | | | 248,153 | | | | 268,316 | |
Valuation allowance | | | (1,322,575 | ) | | | (1,281,208 | ) |
Total net deferred tax assets | | | - | | | | - | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
The Company has maintained a full valuation allowance against the total deferred tax assets for all periods due to the uncertainty of future utilization.
As of December 31, 2022, the Company has net federal and state net operating loss carry forwards of approximately $1,197,000 that begin to expire in 2037.
(15) Stockholders’ Equity
The total number of shares of stock this Corporation is authorized to issue shall be five hundred one million (501,000,000) shares, par value $0.001 per share. Our authorized capital stock consists of 500,000,000 shares of common stock and 1,000,000 shares of blank check preferred stock.
Preferred Stock
On July 10, 2013, the Board of Directors of the Company approved a certificate of amendment to the articles of incorporation and changed the authorized capital stock of the Company to include and authorize 500,000 shares of Preferred Stock, par value $0.001 per share. On October 7, 2020, the Board of Directors of the Company approved a certificate of amendment to the articles of incorporation and changed the total number of authorized shares of Preferred Stock to be 1,000,000 shares, $0.001 per share.
On October 7, 2020, our Board of Directors and our stockholders approved a resolution to amend and restate the certificate of designation of preferences, rights and limitations of Series A Convertible Preferred Stock to restate that there are 401,000 shares of the Company’s blank check Preferred Stock designated as Series A Convertible Preferred Stock. The amended and restated certificate clarifies that the Series A Convertible Preferred Stock convert at a rate of five shares of the Company’s common stock for every share of Series A Convertible Preferred Stock, and also restates that the Series A Convertible Preferred Stock shall be entitled to vote on all matters submitted to shareholders of the Company for each share of Series A Convertible Preferred Stock owned on the record date for the determination of shareholders entitled to vote on such matter or, if no such record date is established, on the date such vote is taken or any written consent of shareholders is solicited. The number of votes entitled to be cast by the holders of the Series A Convertible Preferred Stock equals that number of votes that, together with votes otherwise entitled to be cast by the holders of the Series A Convertible Preferred Stock at a meeting, whether by virtue of stock ownership, proxies, voting trust agreements or otherwise, entitle the holders to exercise 51% of all votes entitled to be cast to approve any action which Nevada law provides may or must be approved by vote or consent of the holders of common stock entitled to vote.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Common Stock:
The Company originally authorized 50,000,000 shares of common stock with a par value of $0.001. Effective May 20, 2014, the Company increased its authorized shares of common stock from 50,000,000 to 500,000,000.
On February 17, 2021, AmpliTech Group Inc., common stock and warrants under the symbols “AMPG” and “AMPGW”, respectively, commenced trading on NASDAQ. In connection with the public offering, 1,371,428 units at an offering price of $7.00 per unit were sold. Each unit issued in the offering consisted of one share of common stock and one warrant. Maxim Group LLC acted as sole book-running manager for the offering. Net proceeds received was $8,119,502.
On February 24, 2021, Maxim Group LLC exercised its overallotment option to purchase an additional 205,714 shares of common stock. Net proceeds received was $1,330,095.
As of December 31, 2021, 210,700 warrants were exercised at an exercise price of $7.00 and 210,700 shares of common stock were issued. Gross proceeds received were $1,474,900.
On April 15, 2021, the Company entered into definitive agreements with certain institutional investors for the sale of 2,715,000 shares of common stock in a registered direct offering priced at-the-market under NASDAQ rules. Concurrently, the Company agreed to issue to the investors, in a private placement, warrants to purchase an aggregate of 1,900,500 shares of common stock at an exercise price of $8.48 per share with a five-year term. Maxim Group LLC acted as the exclusive placement agent for this offering. The shares of common stock as described were offered pursuant to a “shelf” registration statement filed with the SEC on April 1, 2021 and declared effective on April 14, 2021. The aggregate gross proceeds to the Company were approximately $23 million dollars before deducting placement agent’s fees and expenses. The offering closed on April 16, 2021. On April 30, 2021, the Company filed a registration statement providing for the resale of the shares of common stock issuable upon the exercise of the warrants issued in the private placement. The registration statement became effective on May 11, 2021.
On December 15, 2021, 188,442 unregistered shares of AmpliTech’s common stock were issued as part of the Spectrum Semiconductor Materials acquisition for $665,200.
On May 20, 2022, 30,000 restricted stock units at an exercise price of $1.96 were issued to a board advisor. Vesting will occur in equal quarterly installments of 2,500 shares beginning on May 20, 2022.
On May 20, 2022, August 20, 2022 and November 20, 2022, 2,500 shares of common stock were issued, respectively.
On June 17, 2022, 15,000 restricted stock units at an exercise price of $1.97 were issued to three board members. Vesting occurred immediately and 45,000 shares of common stock were issued.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
2020 Equity Incentive Plan:
In October 2020, the Board of Directors and shareholders adopted the Company's 2020 Equity Incentive Plan (the "2020 Plan"), effective as of December 14, 2020. Under the 2020 Plan, the Company reserved 1,250,000 shares of common stock to grant shares of the Company's common stock to employees and individuals who perform services for the Company. The purpose of the 2020 Plan is to attract and retain the best available personnel for positions of substantial responsibility, to provide incentives to individuals who perform services for the Company, and to promote the success of the Company's business. The 2020 Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares, and other stock or cash awards as the Board of Directors may determine.
Stock Options:
On May 20, 2022, the Company granted four employees five-year stock options to purchase shares of common stock (totaling 45,000) according to the Company’s 2020 Plan. The stock options vest in equal quarterly installments over five years commencing on the grant date, with an exercise price of $1.96 per share. The Company also granted two employees five-year stock options to purchase shares of common stock (totaling 2,000) according to the Company’s 2020 Plan. The stock options vest one year from date of grant at an exercise price of $1.96. In addition, the Company granted two advisors to the Board, ten-year stock options to purchase shares of common stock (totaling 35,000) according to the Company’s 2020 Plan. Twenty-five thousand (25,000) stock options vest immediately on date of grant at an exercise price of $1.96, and the balance of ten thousand (10,000) stock options vest in equal quarterly installments over one year commencing on the grant date. The Company has calculated these options' estimated fair market value at $129,325 using the Black-Scholes model, with the following assumptions: expected term ranging from 2.5 to 4.9 years, stock price $1.96, exercise price $1.96, volatility ranging from 136.2% to 141.3%, risk-free rate ranging from 2.67% to 2.80%, and no forfeiture rate.
On June 14, 2022, the Company granted Mr. Maqbool five-year stock options to purchase 100,000 shares of common stock according to the Company’s 2020 Plan. In addition, Ms. Sanfratello and Mr. Flores were each granted five-year stock options to purchase 50,000 shares of common stock. The stock options vest in quarterly installments over a five-year period with an exercise price of $1.72 per share. The Company has calculated these options estimated fair market value at $304,148 using the Black-Scholes model, with the following assumptions: expected term of 4.9 years, stock price of $1.72, exercise price of $1.72, volatility of 138.3%, risk-free rate of 3.61%, and no forfeiture rate.
On August 22, 2022, the Company granted Daniel Mazziota five-year stock options to purchase 25,000 shares of common stock according to the Company’s 2020 Plan. The stock options vest in quarterly installments over a 5-year period with an exercise price of $2.23 per share. The Company has calculated these options estimated fair market value at $47,787 using the Black-Scholes model, with the following assumptions: expected term of 4.5 years, stock price of $2.23, exercise price of $2.23, volatility of 134.5%, risk-free rate of 3.17%, and no forfeiture rate.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
On December 19, 2022, the Company granted one employees ten-year stock options to purchase 3,000 shares of common stock according to the Company’s 2020 Plan. The stock options vest in equal quarterly installments over three years commencing on March 31, 2023 with an exercise price of $1.97 per share. The Company has calculated these options estimated fair market value at $5,275 using the Black-Scholes model, with the following assumptions: expected term of 5.5 years, stock price of $1.97, exercise price of $1.97, volatility of 132.2%, risk-free rate of 3.99%, and no forfeiture rate.
On December 20, 2022, the Company granted Mr. Maqbool ten-year stock options to purchase 100,000 shares of common stock according to the Company’s 2020 Plan. In addition, Ms. Sanfratello and Mr. Flores were each granted ten-year stock options to purchase 50,000, shares of common stock. The stock options vest in quarterly installments over a 5-year period with an exercise price of $1.92 per share. The Company has calculated these options estimated fair market value at $357,425 using the Black-Scholes model, with the following assumptions: expected term of 7.5 years, stock price of $1.92, exercise price of $1.92, volatility of 127.5%, risk-free rate of 3.79%, and no forfeiture rate.
On December 20, 2022, the Company granted Matthew Kappers, Andrew Lee and Daniel Mazziota ten-year stock options to purchase 5,000, 5,000 and 7,500 respectively, shares of common stock according to the Company’s 2020 Plan. The stock options vest in quarterly installments over a 5-year period with an exercise price of $1.92 per share. The Company has calculated these options estimated fair market value at $31,275 using the Black-Scholes model, with the following assumptions: expected term of 7.5 years, stock price of $1.92, exercise price of $1.92, volatility of 127.5%, risk-free rate of 3.79%, and no forfeiture rate.
On December 20, 2022, the Company granted eleven employees and one board advisor ten-year stock options to purchase 85,500 shares of common stock according to the Company’s 2020 Plan. The stock options vest in quarterly installments over a 5-year period with an exercise price of $1.92 per share. The Company has calculated these options estimated fair market value at $152,800 using the Black-Scholes model, with the following assumptions: expected term of 7.5 years, stock price of $1.92, exercise price of $1.92, volatility of 127.5%, risk-free rate of 3.79%, and no forfeiture rate
On June 30, 2021, the Company granted ten-year stock options to purchase shares of common stock (totaling 45,000) according to the Company’s 2020 Plan. to each of our Board of Directors (Mr. Lee, Mr. Kappers, and Mr. Mazziota) ten-year nonqualified stock options to purchase 12,500 shares of common stock (totaling 37,500) according to the Company's 2020 Plan. The stock options vest in full on the date of the grant, with an exercise price of $4.63 per share. The Company has calculated these options' estimated fair market value at $134,550 using the Black-Scholes model, with the following assumptions: expected term 2.5 years, stock price $4.63, exercise price $4.63, volatility 153.1%, risk-free rate 0.36%, and no forfeiture rate.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
On July 26, 2021, the Company granted three employees, a consultant and two advisors to the Board ten-year stock options to purchase shares of common stock (totaling 52,000) according to the Company's 2020 Plan. The stock options vest in equal quarterly installments over three years commencing one year after the grant date, with an exercise price of $3.88 per share. The Company has calculated these options' estimated fair market value at $190,252 using the Black-Scholes model, with the following assumptions: expected term 7.0 years, stock price $3.88, exercise price $3.88, volatility 142.6%, risk-free rate 1.04%, and no forfeiture rate. As amended and effective as of May 20, 2022, 10,000 stock options to purchase shares of common stock that were granted to a Board advisor, vested in full.
On September 29, 2021, the Company granted one employee five-year stock options to purchase 1,000 shares of common stock according to the Company’s 2020 Plan. The stock options vest 50% on the date of grant and 50% on the one-year anniversary of the date of grant. The Company has calculated these options' estimated fair market value at $2,868 using the Black-Scholes model, with the following assumptions: expected term 3.0 years, stock price $3.62, exercise price $3.62, volatility 147.2%, risk-free rate 0.55%, and no forfeiture rate.
On November 26, 2021, the Company granted two officers, one board member, two board advisors and one employee stock options to purchase 200,000 shares of common stock according to the Company’s 2020 Plan. The stock options vest immediately with an exercise price of $3.52 per share. The Company has calculated these options' estimated fair market value at $532,562 using the Black-Scholes model, with the following assumptions: expected term 2.5 years, stock price $3.52, exercise price $3.52, volatility 146.7%, risk-free rate 0.83%, and no forfeiture rate.
On November 30, 2021, the Company granted two employees five-year stock options to purchase 15,000 shares of common stock according to the Company’s 2020 Plan. The stock options vest 12 months after the initial date of employment for each employee. The Company has calculated these options' estimated fair market value at $43,077 using the Black-Scholes model, with the following assumptions: expected term 3.0 years, stock price $3.88, exercise price $3.88, volatility 144.2%, risk-free rate 0.81%, and no forfeiture rate.
Below is a table summarizing the changes in stock options outstanding for the year ended December 31, 2022:
| | Number of | | | Weighted Average | |
| | Options | | | Exercise Price ($) | |
Outstanding at December 31, 2021 | | | 305,500 | | | $ | 3.74 | |
Granted | | | 613,000 | | | $ | 1.87 | |
Exercised | | | - | | | | - | |
Expired | | | (2,500 | ) | | $ | 3.88 | |
Outstanding at December 31, 2022 | | | 916,000 | | | $ | 2.49 | |
Exercisable at December 31, 2022 | | | 334,042 | | | $ | 3.30 | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
As of December 31, 2022, all outstanding stock options were issued according to the Company's 2020 Plan, and there remains 259,000 shares of common stock available for future issuance under the 2020 Plan.
Stock-based compensation expense related to stock options of $244,631 and $692,076 was recorded for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the remaining unrecognized compensation cost related to non-vested stock options is $985,490 and is expected to be recognized over 5 years. The outstanding stock options have a weighted average remaining contractual life of 6.34 years and a total intrinsic value of $154,170.
Warrants:
Effective February 19, 2021, Amplitech Group Inc., common stock and warrants under the symbols "AMPG" and "AMPGW," respectively, commenced trading on NASDAQ. In connection with the public offering, 1,371,428 units sold at an offering price of $7.00 per unit. Each unit issued in the offering consisted of one share of common stock and one warrant. Maxim Group LLC acted as sole book-running manager for the offering and partially exercised its overallotment option to purchase 205,714 warrants at the public offering price. The warrants expire ten years from the date of issuance.
Effective April 16, 2021, the Company entered into definitive agreements with certain institutional investors to sell 2,715,000 shares of common stock in a registered direct offering priced at the market under NASDAQ rules. Concurrently, the Company agreed to issue to the investors, in a private placement, warrants to purchase an aggregate of 1,900,500 shares of common stock at an exercise price of $8.48 per share with a five-year term.
For the year ended December 31, 2021, 210,700 warrants were exercised at $7.00, resulting in the issuance of 210,700 shares of common stock.
On July 20, 2021, in connection with a product development agreement with an unrelated party, the Company issued warrants to purchase 30,000 shares of common stock. The warrants vest in one year from issuance, with an exercise price of $5.00 per share. The Company has calculated these warrants estimated fair market value at $88,803 using the Black-Scholes model, with the following assumptions: expected term 3.0 years, stock price $3.80, exercise price $5.00, volatility 149.8%, risk-free rate 0.37%, and no forfeiture rate.
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Below is a table summarizing the changes in warrants outstanding for the year ended December 31, 2022:
| | Number of | | | Weighted Average | |
| | Warrants | | | Exercise Price ($) | |
Outstanding at December 31, 2021 | | | 3,296,942 | | | $ | 7.83 | |
Granted | | | - | | | | - | |
Exercised | | | - | | | | - | |
Expired | | | - | | | | - | |
Outstanding at December 31, 2022 | | | 3,296,942 | | | $ | 7.83 | |
Exercisable at December 31, 2022 | | | 3,296,942 | | | $ | 7.83 | |
Stock-based compensation expense related to warrants of $48,902 and $39,901 was recorded for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the remaining unrecognized compensation cost related to non-vested warrants is $0. The outstanding warrants have a weighted average remaining contractual life of 3.23 years and a total intrinsic value of $0.
Restricted Stock Units:
On May 20, 2022, 30,000 restricted stock units at an exercise price of $1.96 were issued to a board advisor. Vesting will occur in equal quarterly installments of 2,500 shares beginning on May 20, 2022. As of December 31, 2022, 7,500 RSU’s have vested.
On June 17, 2022, the Company granted restricted stock awards under the Company’s 2020 Plan to directors of the Company for an aggregate of 45,000 shares of common stock (15,000 each) valued at $88,650. These restricted stock awards vested immediately.
Below is a table summarizing the changes in restricted stock units outstanding for the year ended December 31, 2022:
| | Number of | | | Weighted Average | |
| | RSU’s | | | Exercise Price ($) | |
Outstanding at December 31, 2021 | | | - | | | | - | |
Granted | | | 75,000 | | | $ | 1.97 | |
Exercised | | | (52,500 | ) | | $ | 1.97 | |
Expired | | | - | | | | - | |
Outstanding at December 31, 2022 | | | 22,500 | | | $ | 1.96 | |
Exercisable at December 31, 2022 | | - | | | $ | - | |
AmpliTech Group, Inc.
Notes To Consolidated Financial Statements
For the Years Ended December 31, 2022 and 2021
Stock-based compensation expense related to restricted stock units of $105,593 was recorded for the year ended December 31, 2022. As of December 31, 2022, the remaining unrecognized compensation cost related to non-vested restricted stock units is $41,857. The outstanding restricted stock units have a weighted average remaining contractual life of 2.14 years and a total intrinsic value of $47,700.
(16) Commitments and Contingencies
On November 19, 2021, AmpliTech Group, Inc. entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Spectrum Semiconductor Materials Inc. (the "Seller" or “SSM”), pursuant to which AmpliTech would acquire substantially all of the assets of the Company (the “Acquisition”). The Acquisition was completed on December 15, 2021.
Within forty (40) days after December 31, 2022, AmpliTech, as stipulated in the Purchase Agreement, prepared and delivered to Seller a statement setting forth its calculation of Two Years Net Revenues of the business, or the “Revenue Statement”. The Revenues Adjustment shall be an amount equal to 25% of two years net revenues minus $20,000,000. If the Revenues Adjustment is a positive number, Buyer shall pay to Seller an amount equal to the Revenues Adjustment. If the Revenues Adjustment is a negative number, Seller shall pay to Buyer and amount equal to the Revenues Adjustment. The fair value of the revenue adjustment was determined to be $2,180,826, an increase of $815,788 as previously recorded as of December 31, 2021. This amount is owed to Seller and recorded as a contingent liability as of December 31, 2022.
(17) Subsequent events
On January 20,2023, the current Board of Directors, renewed their directors’ agreements and shall be issued 15,000 restricted stock units (RSU’s) pursuant to the Company’s 2020 Equity Incentive Plan.
As of March 14, 2023, the Company closed the line of credit of $750,000 and the equipment line of credit for $500,000. Both lines of credit had a $0 balance. All UCC filings on the Company assets have been released as well as the President’s personal guarantee.
On March 20, 2023, the revenue earnout of $2,180,826 was paid to the Seller.
On March 27, 2023, the Company amended the employment agreement with Jorge Flores to extend its term to March 20, 2024. The amendment was effective March 20, 2023.